Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Buttonhole versus Stepladder Cannulation for Home Hemodialysis: A Multicenter, Randomized, Pilot Trial.

Huang SS, MacRae J, Ross D, Imtiaz R, Hollingsworth B, Nesrallah GE, Copland MA, McFarlane PA, Chan CT, Zimmerman D.

Clin J Am Soc Nephrol. 2019 Mar 7;14(3):403-410. doi: 10.2215/CJN.08310718. Epub 2019 Jan 18.

PMID:
30659057
2.

Hypertension Canada's 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children.

Nerenberg KA, Zarnke KB, Leung AA, Dasgupta K, Butalia S, McBrien K, Harris KC, Nakhla M, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Padwal RS, Tran KC, Grover S, Rabkin SW, Moe GW, Howlett JG, Lindsay P, Hill MD, Sharma M, Field T, Wein TH, Shoamanesh A, Dresser GK, Hamet P, Herman RJ, Burgess E, Gryn SE, Grégoire JC, Lewanczuk R, Poirier L, Campbell TS, Feldman RD, Lavoie KL, Tsuyuki RT, Honos G, Prebtani APH, Kline G, Schiffrin EL, Don-Wauchope A, Tobe SW, Gilbert RE, Leiter LA, Jones C, Woo V, Hegele RA, Selby P, Pipe A, McFarlane PA, Oh P, Gupta M, Bacon SL, Kaczorowski J, Trudeau L, Campbell NRC, Hiremath S, Roerecke M, Arcand J, Ruzicka M, Prasad GVR, Vallée M, Edwards C, Sivapalan P, Penner SB, Fournier A, Benoit G, Feber J, Dionne J, Magee LA, Logan AG, Côté AM, Rey E, Firoz T, Kuyper LM, Gabor JY, Townsend RR, Rabi DM, Daskalopoulou SS; Hypertension Canada.

Can J Cardiol. 2018 May;34(5):506-525. doi: 10.1016/j.cjca.2018.02.022. Epub 2018 Mar 1.

PMID:
29731013
3.

Resistant Hypertension in Adults With Type 1 or 2 Diabetes: A Structured Diagnostic Approach.

McFarlane PA.

Can J Diabetes. 2018 Apr;42(2):173-178. doi: 10.1016/j.jcjd.2018.01.001. Epub 2018 Jan 8. Review.

PMID:
29602405
4.

Managing the Course of Kidney Disease in Adults With Type 2 Diabetes: From the Old to the New.

Goldenberg RM, Berall M, Chan CTM, Cherney DZI, Lovshin JA, McFarlane PA, Senior PA, Verma S, Weinstein JJ.

Can J Diabetes. 2018 Jun;42(3):325-334. doi: 10.1016/j.jcjd.2017.06.008. Epub 2017 Aug 16. Review.

PMID:
28822777
5.

Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults.

Leung AA, Daskalopoulou SS, Dasgupta K, McBrien K, Butalia S, Zarnke KB, Nerenberg K, Harris KC, Nakhla M, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Tran KC, Tobe SW, Ruzicka M, Burns KD, Vallée M, Prasad GVR, Gryn SE, Feldman RD, Selby P, Pipe A, Schiffrin EL, McFarlane PA, Oh P, Hegele RA, Khara M, Wilson TW, Penner SB, Burgess E, Sivapalan P, Herman RJ, Bacon SL, Rabkin SW, Gilbert RE, Campbell TS, Grover S, Honos G, Lindsay P, Hill MD, Coutts SB, Gubitz G, Campbell NRC, Moe GW, Howlett JG, Boulanger JM, Prebtani A, Kline G, Leiter LA, Jones C, Côté AM, Woo V, Kaczorowski J, Trudeau L, Tsuyuki RT, Hiremath S, Drouin D, Lavoie KL, Hamet P, Grégoire JC, Lewanczuk R, Dresser GK, Sharma M, Reid D, Lear SA, Moullec G, Gupta M, Magee LA, Logan AG, Dionne J, Fournier A, Benoit G, Feber J, Poirier L, Padwal RS, Rabi DM; Hypertension Canada.

Can J Cardiol. 2017 May;33(5):557-576. doi: 10.1016/j.cjca.2017.03.005. Epub 2017 Mar 10. Erratum in: Can J Cardiol. 2017 Dec;33(12 ):1733-1734.

PMID:
28449828
6.

Clinical safety and performance of VIVIA: a novel home hemodialysis system.

Bernardo AA, Marbury TC, McFarlane PA, Pauly RP, Amdahl M, Demers J, Hutchcraft AM, Leypoldt JK, Minkus M, Muller M, Stallard R, Culleton BF.

Nephrol Dial Transplant. 2017 Apr 1;32(4):685-692. doi: 10.1093/ndt/gfw044.

PMID:
27190336
7.

Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension.

Leung AA, Nerenberg K, Daskalopoulou SS, McBrien K, Zarnke KB, Dasgupta K, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Tobe SW, Ruzicka M, Burns KD, Vallée M, Prasad GV, Lebel M, Feldman RD, Selby P, Pipe A, Schiffrin EL, McFarlane PA, Oh P, Hegele RA, Khara M, Wilson TW, Penner SB, Burgess E, Herman RJ, Bacon SL, Rabkin SW, Gilbert RE, Campbell TS, Grover S, Honos G, Lindsay P, Hill MD, Coutts SB, Gubitz G, Campbell NR, Moe GW, Howlett JG, Boulanger JM, Prebtani A, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Trudeau L, Petrella RJ, Hiremath S, Drouin D, Lavoie KL, Hamet P, Fodor G, Grégoire JC, Lewanczuk R, Dresser GK, Sharma M, Reid D, Lear SA, Moullec G, Gupta M, Magee LA, Logan AG, Harris KC, Dionne J, Fournier A, Benoit G, Feber J, Poirier L, Padwal RS, Rabi DM; CHEP Guidelines Task Force.

Can J Cardiol. 2016 May;32(5):569-88. doi: 10.1016/j.cjca.2016.02.066. Epub 2016 Mar 10.

PMID:
27118291
8.

The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Daskalopoulou SS, Rabi DM, Zarnke KB, Dasgupta K, Nerenberg K, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, McKay DW, Tremblay G, McLean D, Tobe SW, Ruzicka M, Burns KD, Vallée M, Ramesh Prasad GV, Lebel M, Feldman RD, Selby P, Pipe A, Schiffrin EL, McFarlane PA, Oh P, Hegele RA, Khara M, Wilson TW, Brian Penner S, Burgess E, Herman RJ, Bacon SL, Rabkin SW, Gilbert RE, Campbell TS, Grover S, Honos G, Lindsay P, Hill MD, Coutts SB, Gubitz G, Campbell NR, Moe GW, Howlett JG, Boulanger JM, Prebtani A, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Trudeau L, Petrella RJ, Hiremath S, Stone JA, Drouin D, Lavoie KL, Hamet P, Fodor G, Grégoire JC, Fournier A, Lewanczuk R, Dresser GK, Sharma M, Reid D, Benoit G, Feber J, Harris KC, Poirier L, Padwal RS.

Can J Cardiol. 2015 May;31(5):549-68. doi: 10.1016/j.cjca.2015.02.016. Review.

PMID:
25936483
9.

Funding and planning: what you need to know for starting or expanding a home hemodialysis program.

Howard K, McFarlane PA, Marshall MR, Eastwood DO, Morton RL.

Hemodial Int. 2015 Apr;19 Suppl 1:S23-42. doi: 10.1111/hdi.12243. Review.

PMID:
25925821
10.

Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 2: treatment.

Easaw JC, Shea-Budgell MA, Wu CM, Czaykowski PM, Kassis J, Kuehl B, Lim HJ, MacNeil M, Martinusen D, McFarlane PA, Meek E, Moodley O, Shivakumar S, Tagalakis V, Welch S, Kavan P.

Curr Oncol. 2015 Apr;22(2):144-55. doi: 10.3747/co.22.2587.

11.

Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 1: prophylaxis.

Easaw JC, Shea-Budgell MA, Wu CM, Czaykowski PM, Kassis J, Kuehl B, Lim HJ, MacNeil M, Martinusen D, McFarlane PA, Meek E, Moodley O, Shivakumar S, Tagalakis V, Welch S, Kavan P.

Curr Oncol. 2015 Apr;22(2):133-43. doi: 10.3747/co.22.2586.

12.

Six cases of silicosis: implications for health surveillance of stonemasons.

Nicol LM, McFarlane PA, Hirani N, Reid PT.

Occup Med (Lond). 2015 Apr;65(3):220-5. doi: 10.1093/occmed/kqu209. Epub 2015 Mar 4.

PMID:
25744972
13.

Testing for albuminuria in 2014.

McFarlane PA.

Can J Diabetes. 2014 Oct;38(5):372-5. doi: 10.1016/j.jcjd.2014.07.221. Review.

PMID:
25284700
14.

The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Dasgupta K, Quinn RR, Zarnke KB, Rabi DM, Ravani P, Daskalopoulou SS, Rabkin SW, Trudeau L, Feldman RD, Cloutier L, Prebtani A, Herman RJ, Bacon SL, Gilbert RE, Ruzicka M, McKay DW, Campbell TS, Grover S, Honos G, Schiffrin EL, Bolli P, Wilson TW, Lindsay P, Hill MD, Coutts SB, Gubitz G, Gelfer M, Vallée M, Prasad GV, Lebel M, McLean D, Arnold JM, Moe GW, Howlett JG, Boulanger JM, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Burns KD, Petrella RJ, Hiremath S, Milot A, Stone JA, Drouin D, Lavoie KL, Lamarre-Cliche M, Tremblay G, Hamet P, Fodor G, Carruthers SG, Pylypchuk GB, Burgess E, Lewanczuk R, Dresser GK, Penner SB, Hegele RA, McFarlane PA, Khara M, Pipe A, Oh P, Selby P, Sharma M, Reid DJ, Tobe SW, Padwal RS, Poirier L; Canadian Hypertension Education Program.

Can J Cardiol. 2014 May;30(5):485-501. doi: 10.1016/j.cjca.2014.02.002. Epub 2014 Feb 22. Review.

15.

Vascular access for intensive maintenance hemodialysis: a systematic review for a Canadian Society of Nephrology clinical practice guideline.

Mustafa RA, Zimmerman D, Rioux JP, Suri RS, Gangji A, Steele A, MacRae J, Pauly RP, Perkins DN, Chan CT, Copland M, Komenda P, McFarlane PA, Lindsay R, Pierratos A, Nesrallah GE.

Am J Kidney Dis. 2013 Jul;62(1):112-31. doi: 10.1053/j.ajkd.2013.03.028. Review.

PMID:
23773840
16.

A comparison of the assessment and management of cardiometabolic risk in patients with and without type 2 diabetes mellitus in Canadian primary care.

Teoh H, Després JP, Dufour R, Fitchett DH, Goldin L, Goodman SG, Harris SB, Langer A, Lau DC, Lonn EM, Mancini GB, McFarlane PA, Poirier P, Rabasa-Lhoret R, Tan MK, Leiter LA.

Diabetes Obes Metab. 2013 Dec;15(12):1093-100. doi: 10.1111/dom.12134. Epub 2013 Jun 11.

PMID:
23683111
17.

Dialysate calcium concentration and mineral metabolism in long and long-frequent hemodialysis: a systematic review and meta-analysis for a Canadian Society of Nephrology clinical practice guideline.

Zimmerman DL, Nesrallah GE, Chan CT, Copland M, Komenda P, McFarlane PA, Gangji A, Lindsay R, MacRae J, Pauly RP, Perkins DN, Pierratos A, Rioux JP, Steele A, Suri RS, Mustafa RA.

Am J Kidney Dis. 2013 Jul;62(1):97-111. doi: 10.1053/j.ajkd.2013.02.357. Epub 2013 Apr 13. Review.

PMID:
23591289
18.

Canadian Society of Nephrology guidelines for the management of patients with ESRD treated with intensive hemodialysis.

Nesrallah GE, Mustafa RA, MacRae J, Pauly RP, Perkins DN, Gangji A, Rioux JP, Steele A, Suri RS, Chan CT, Copland M, Komenda P, McFarlane PA, Pierratos A, Lindsay R, Zimmerman DL.

Am J Kidney Dis. 2013 Jul;62(1):187-98. doi: 10.1053/j.ajkd.2013.02.351. Epub 2013 Apr 6. Review.

PMID:
23566638
19.

The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Hackam DG, Quinn RR, Ravani P, Rabi DM, Dasgupta K, Daskalopoulou SS, Khan NA, Herman RJ, Bacon SL, Cloutier L, Dawes M, Rabkin SW, Gilbert RE, Ruzicka M, McKay DW, Campbell TS, Grover S, Honos G, Schiffrin EL, Bolli P, Wilson TW, Feldman RD, Lindsay P, Hill MD, Gelfer M, Burns KD, Vallée M, Prasad GV, Lebel M, McLean D, Arnold JM, Moe GW, Howlett JG, Boulanger JM, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Trudeau L, Petrella RJ, Milot A, Stone JA, Drouin D, Lavoie KL, Lamarre-Cliche M, Godwin M, Tremblay G, Hamet P, Fodor G, Carruthers SG, Pylypchuk GB, Burgess E, Lewanczuk R, Dresser GK, Penner SB, Hegele RA, McFarlane PA, Sharma M, Reid DJ, Tobe SW, Poirier L, Padwal RS; Canadian Hypertension Education Program.

Can J Cardiol. 2013 May;29(5):528-42. doi: 10.1016/j.cjca.2013.01.005. Epub 2013 Mar 29.

PMID:
23541660
20.

Identification and management of patients at elevated cardiometabolic risk in canadian primary care: how well are we doing?

Teoh H, Després JP, Dufour R, Fitchett DH, Goldin L, Goodman SG, Harris SB, Langer A, Lau DC, Lonn EM, John Mancini GB, McFarlane PA, Poirier P, Rabasa-Lhoret R, Tan MK, Leiter LA.

Can J Cardiol. 2013 Aug;29(8):960-8. doi: 10.1016/j.cjca.2012.12.001. Epub 2013 Mar 7.

PMID:
23465284
21.

Use of home hemodialysis after peritoneal dialysis technique failure.

Cinà DP, Dacouris N, Kashani M, Unana B, Cook R, Fung J, Delacruz J, Zaltzman AP, McFarlane PA, Perl J.

Perit Dial Int. 2013 Jan-Feb;33(1):96-9. doi: 10.3747/pdi.2012.00022. No abstract available.

22.

Factors associated with suboptimal initiation of dialysis despite early nephrologist referral.

Hughes SA, Mendelssohn JG, Tobe SW, McFarlane PA, Mendelssohn DC.

Nephrol Dial Transplant. 2013 Feb;28(2):392-7. doi: 10.1093/ndt/gfs431. Epub 2012 Dec 4.

PMID:
23222418
23.

Cost-effectiveness analysis of therapies for chronic kidney disease patients on dialysis: a case for excluding dialysis costs.

Grima DT, Bernard LM, Dunn ES, McFarlane PA, Mendelssohn DC.

Pharmacoeconomics. 2012 Nov 1;30(11):981-9. doi: 10.2165/11599390-000000000-00000.

PMID:
22946789
24.

The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy.

Daskalopoulou SS, Khan NA, Quinn RR, Ruzicka M, McKay DW, Hackam DG, Rabkin SW, Rabi DM, Gilbert RE, Padwal RS, Dawes M, Touyz RM, Campbell TS, Cloutier L, Grover S, Honos G, Herman RJ, Schiffrin EL, Bolli P, Wilson T, Feldman RD, Lindsay MP, Hemmelgarn BR, Hill MD, Gelfer M, Burns KD, Vallée M, Prasad GV, Lebel M, McLean D, Arnold JM, Moe GW, Howlett JG, Boulanger JM, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Trudeau L, Bacon SL, Petrella RJ, Milot A, Stone JA, Drouin D, Lamarre-Cliché M, Godwin M, Tremblay G, Hamet P, Fodor G, Carruthers SG, Pylypchuk G, Burgess E, Lewanczuk R, Dresser GK, Penner B, Hegele RA, McFarlane PA, Sharma M, Campbell NR, Reid D, Poirier L, Tobe SW; Canadian Hypertension Education Program.

Can J Cardiol. 2012 May;28(3):270-87. doi: 10.1016/j.cjca.2012.02.018. Review.

PMID:
22595447
25.

Poor achievement of guidelines-recommended targets in type 2 diabetes: findings from a contemporary prospective cohort study.

Braga MF, Casanova A, Teoh H, Gerstein HC, Fitchett DH, Honos G, McFarlane PA, Ur E, Yale JF, Langer A, Goodman SG, Leiter LA; Diabetes Registry to Improve Vascular Events [DRIVE] Investigators.

Int J Clin Pract. 2012 May;66(5):457-64. doi: 10.1111/j.1742-1241.2012.02894.x. Epub 2012 Mar 27.

PMID:
22452524
26.

Intensive hemodialysis associates with improved survival compared with conventional hemodialysis.

Nesrallah GE, Lindsay RM, Cuerden MS, Garg AX, Port F, Austin PC, Moist LM, Pierratos A, Chan CT, Zimmerman D, Lockridge RS, Couchoud C, Chazot C, Ofsthun N, Levin A, Copland M, Courtney M, Steele A, McFarlane PA, Geary DF, Pauly RP, Komenda P, Suri RS.

J Am Soc Nephrol. 2012 Apr;23(4):696-705. doi: 10.1681/ASN.2011070676. Epub 2012 Feb 23.

27.

Regression of left ventricular mass following conversion from conventional hemodialysis to thrice weekly in-centre nocturnal hemodialysis.

Wald R, Yan AT, Perl J, Jiang D, Donnelly MS, Leong-Poi H, McFarlane PA, Weinstein JJ, Goldstein MB.

BMC Nephrol. 2012 Jan 19;13:3. doi: 10.1186/1471-2369-13-3.

28.

The STARRT trial: a cost comparison of optimal vs sub-optimal initiation of dialysis in Canada.

Piwko C, Vicente C, Marra L, Jivraj F, Appel E, Wolpin J, Camacho F, Mendelssohn DC, McFarlane PA.

J Med Econ. 2012;15(1):96-104. doi: 10.3111/13696998.2011.630850. Epub 2011 Oct 28.

PMID:
21988636
29.

The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy.

Rabi DM, Daskalopoulou SS, Padwal RS, Khan NA, Grover SA, Hackam DG, Myers MG, McKay DW, Quinn RR, Hemmelgarn BR, Cloutier L, Bolli P, Hill MD, Wilson T, Penner B, Burgess E, Lamarre-Cliché M, McLean D, Schiffrin EL, Honos G, Mann K, Tremblay G, Milot A, Chockalingam A, Rabkin SW, Dawes M, Touyz RM, Burns KD, Ruzicka M, Campbell NR, Vallée M, Prasad GV, Lebel M, Campbell TS, Lindsay MP, Herman RJ, Larochelle P, Feldman RD, Arnold JM, Moe GW, Howlett JG, Trudeau L, Bacon SL, Petrella RJ, Lewanczuk R, Stone JA, Drouin D, Boulanger JM, Sharma M, Hamet P, Fodor G, Dresser GK, Carruthers SG, Pylypchuk G, Gilbert RE, Leiter LA, Jones C, Ogilvie RI, Woo V, McFarlane PA, Hegele RA, Poirier L, Tobe SW; Canadian Hypertension Education Program.

Can J Cardiol. 2011 Jul-Aug;27(4):415-433.e1-2. doi: 10.1016/j.cjca.2011.03.015. English, French.

PMID:
21801975
30.

Identification and management of cardiometabolic risk in Canada: a position paper by the cardiometabolic risk working group (executive summary).

Cardiometabolic Risk Working Group: Executive Committee, Leiter LA, Fitchett DH, Gilbert RE, Gupta M, Mancini GB, McFarlane PA, Ross R, Teoh H, Verma S, Anand S, Camelon K, Chow CM, Cox JL, Després JP, Genest J, Harris SB, Lau DC, Lewanczuk R, Liu PP, Lonn EM, McPherson R, Poirier P, Qaadri S, Rabasa-Lhoret R, Rabkin SW, Sharma AM, Steele AW, Stone JA, Tardif JC, Tobe S, Ur E.

Can J Cardiol. 2011 Mar-Apr;27(2):124-31. doi: 10.1016/j.cjca.2011.01.016. Review.

PMID:
21459258
31.

Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group.

Cardiometabolic Risk Working Group: Executive Committee, Leiter LA, Fitchett DH, Gilbert RE, Gupta M, Mancini GB, McFarlane PA, Ross R, Teoh H, Verma S, Anand S, Camelon K, Chow CM, Cox JL, Després JP, Genest J, Harris SB, Lau DC, Lewanczuk R, Liu PP, Lonn EM, McPherson R, Poirier P, Qaadri S, Rabasa-Lhoret R, Rabkin SW, Sharma AM, Steele AW, Stone JA, Tardif JC, Tobe S, Ur E.

Can J Cardiol. 2011 Mar-Apr;27(2):e1-e33. doi: 10.1016/j.cjca.2010.12.054. Review.

PMID:
21459257
32.

Nocturnal hemodialysis: effects on solute clearance, quality of life, and patient survival.

McFarlane PA.

Curr Opin Nephrol Hypertens. 2011 Mar;20(2):182-8. doi: 10.1097/MNH.0b013e3283437046. Review.

PMID:
21252663
33.

Use of the BioHole™ device for the creation of tunnel tracks for buttonhole cannulation of fistula for hemodialysis.

Marticorena RM, Hunter J, Macleod S, Petershofer E, Kashani M, DE LA Cruz J, Cook R, Dacoiris N, McFarlane PA, Goldstein MB, Donnelly SM.

Hemodial Int. 2011 Apr;15(2):243-9. doi: 10.1111/j.1542-4758.2010.00506.x. Epub 2011 Jan 20.

PMID:
21251191
34.

Should patients remain on intensive hemodialysis rather than choosing to receive a kidney transplant?

McFarlane PA.

Semin Dial. 2010 Sep-Oct;23(5):516-9. doi: 10.1111/j.1525-139X.2010.00740.x. Review.

PMID:
21039877
35.

Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada.

Braga M, Casanova A, Teoh H, Dawson KC, Gerstein HC, Fitchett DH, Harris SB, Honos G, McFarlane PA, Steele A, Ur E, Yale JF, Langer A, Goodman SG, Leiter LA; Diabetes Registry to Improve Vascular Events (DRIVE) Investigators.

Can J Cardiol. 2010 Jun-Jul;26(6):297-302.

36.

The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.

Hackam DG, Khan NA, Hemmelgarn BR, Rabkin SW, Touyz RM, Campbell NR, Padwal R, Campbell TS, Lindsay MP, Hill MD, Quinn RR, Mahon JL, Herman RJ, Schiffrin EL, Ruzicka M, Larochelle P, Feldman RD, Lebel M, Poirier L, Arnold JM, Moe GW, Howlett JG, Trudeau L, Bacon SL, Petrella RJ, Milot A, Stone JA, Drouin D, Boulanger JM, Sharma M, Hamet P, Fodor G, Dresser GK, Carruthers SG, Pylypchuk G, Burgess ED, Burns KD, Vallée M, Prasad GV, Gilbert RE, Leiter LA, Jones C, Ogilvie RI, Woo V, McFarlane PA, Hegele RA, Tobe SW; Canadian Hypertension Education Program.

Can J Cardiol. 2010 May;26(5):249-58. Review.

37.

International trends in erythropoietin use and hemoglobin levels in hemodialysis patients.

McFarlane PA, Pisoni RL, Eichleay MA, Wald R, Port FK, Mendelssohn D.

Kidney Int. 2010 Jul;78(2):215-23. doi: 10.1038/ki.2010.108. Epub 2010 Apr 28.

38.

More of the same: improving outcomes through intensive hemodialysis.

McFarlane PA.

Semin Dial. 2009 Nov-Dec;22(6):598-602. doi: 10.1111/j.1525-139X.2009.00666.x. Review.

PMID:
20017828
39.

Glutathione and riboflavin status in supplemented patients undergoing home nocturnal hemodialysis versus standard hemodialysis.

Kannampuzha J, Donnelly SM, McFarlane PA, Chan CT, House JD, Pencharz PB, Darling PB.

J Ren Nutr. 2010 May;20(3):199-208. doi: 10.1053/j.jrn.2009.09.002. Epub 2009 Nov 12.

PMID:
19913440
40.

A simple method to create buttonhole cannulation tracks in a busy hemodialysis unit.

Marticorena RM, Hunter J, Cook R, Kashani M, Delacruz J, Petershofer E, Macleod S, Dacouris N, McFarlane PA, Donnelly SM, Goldstein MB.

Hemodial Int. 2009 Jul;13(3):316-21. doi: 10.1111/j.1542-4758.2009.00373.x. Epub 2009 Jun 8.

PMID:
19515069
41.

Standardized preplanned patient education to encourage transfer from hospital hemodialysis to home dialysis.

Motiwala SS, McFarlane PA.

Perit Dial Int. 2008 Jul-Aug;28(4):403-7. No abstract available.

PMID:
18556384
42.

Intensified hemodialysis regimens: neglected treatment options for children and adolescents.

Müller D, Zimmering M, Chan CT, McFarlane PA, Pierratos A, Querfeld U.

Pediatr Nephrol. 2008 Oct;23(10):1729-36. doi: 10.1007/s00467-008-0783-4. Epub 2008 Mar 12. Review.

PMID:
18335254
43.

Lessons for dialysis investigators from the Steno-2 Study.

McFarlane PA.

J Nephrol. 2008 Jan-Feb;21(1):6-13.

PMID:
18264929
44.

A change from subcutaneous to intravenous erythropoietin increases the cost of anemia therapy.

McFarlane PA, Hillmer MP, Dacouris N.

Nephron Clin Pract. 2007;107(3):c90-6. Epub 2007 Sep 21.

PMID:
17890876
45.

Estimating preference scores in conventional and home nocturnal hemodialysis patients.

McFarlane PA, Pierratos A, Bayoumi AM, Redelmeier DA.

Clin J Am Soc Nephrol. 2007 May;2(3):477-83. Epub 2007 Apr 4.

46.

Pharyngeal narrowing in end-stage renal disease: implications for obstructive sleep apnoea.

Beecroft JM, Hoffstein V, Pierratos A, Chan CT, McFarlane PA, Hanly PJ.

Eur Respir J. 2007 Nov;30(5):965-71. Epub 2007 Jul 11.

47.

Sevelamer and extension studies.

McFarlane PA.

Kidney Int. 2007 Jul;72(2):225-6. No abstract available.

48.

Improving outcomes in diabetes and chronic kidney disease: the basis for Canadian guidelines.

McFarlane PA, Tobe SW, Culleton B.

Can J Cardiol. 2007 May 15;23(7):585-90. Review.

49.
50.

Occult nephrolithiasis in prospective kidney donors: a source for hematuria.

Prasad GV, McFarlane PA.

Transplantation. 2006 Sep 27;82(6):849-50. No abstract available.

PMID:
17006335

Supplemental Content

Loading ...
Support Center